The Cardio Vascular Clinical Trialists Forum (CVCT) serves as a unique think tank, focusing on the latest critical trials in the fields of CardioVascular, CardioRenal, and Cardiometabolic health. It provides a platform for authoritative stakeholders to spend hours delving into individual trials, examining them both individually and in context. The forum aims to foster collaboration, brainstorming, and knowledge-sharing among key clinical trial players.
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
